Ls -1x Alphabet (GOOS) Quote

BILL GATES - WHO - CYTODYN????????????

Free Fortnite Codes Links

Fortnite codes working in 2024

Free Fortnite Codes Links

Fortnite codes working in 2024

Trodelvey OS improvement was/ is :

Triple-Negative Breast Cancer (TNBC):

Trodelvy has shown a significant improvement in overall survival for TNBC patients who haven't received treatment for cancer spreading to the brain [Drugs.com]. The median overall survival with T

He emailed me and said the buyback program started last week

NOPAIN Act
Jan. 1, 2025

https://www.congress.gov/bill/117th-congress/house-bill/3259/text?s=2&r=1&q=%7B%22search%22%3A%22NOPAIN+ACT%22%7D

Just to highlight a few points::

(G) ACCESS TO NON-OPIOID TREATMENTS FOR PAIN.—
“(i) IN GENERAL.—

Post was about what price warrants can be exercised not what would happen to the share price after financing news. $10.38 is just one stop along the way up after financing news.

It is uncertain how far up the share price will go after major financing news but my prediction is a minimu

No doubt about it . XERI might get the fixed amount of only 298,395 XTIA shares. That's a real shame considering XERI had $5.4 mil in this JV . What's the SP of XTIA at close today a whopping .947. So that makes XERI investment for 298,395@.947 WORTH only $282580 That's the bottom line.

An OPEN LETTER
To: Robert and Ellen Holcomb, 29th May 2024
Directors Holcomb Energy Systems,
7337 International Place,
Sarasota, Fl 34240. USA.

You are aware:
1. Robert and Ellen Holcomb, Holcomb Energy system LLC. (HES), and Holcomb scientific Resea

Valley co-criminal to Ron, Claycamp and the Holcomb's move on, nobody cares. Your days are numbered and coming.

GILD Paid $21bn for Trodelvey

SUKU BITCOIN SHIBADOGEX BONK BONK ☝️🤑🖕🌪️🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀 XRP🏦💵💵💵💵💵

Gilead Sciences Says Phase 3 Trial in Urothelial Cancer Misses Primary Target
(MT Newswires)
Gilead Sciences (GILD) said Thursday its late-stage study of Trodelvy in locally advanced or metastatic urothelial cancer didn't meet its primary endpoint of overall survival in the intention-t

*GILEAD: STUDY DID NOT MEET PRIMARY ENDPOINT

Gilead’s Trodelvy woes rise with failed bladder cancer trial
News

Gilead Sciences' TROP2-directed drug Trodelvy has missed the target in another clinical trial, this time in urothelial carcinoma, the most common form of bladder cancer.

The results of the TROPiCS-

XHG 1.37 + 100% NVOS .73 +61%

XHG
XChange TECINC DRC
1.37
+0.6849
+99.97%

NVOS
Novo Integrated Sc.
0.714
+0.263
+58.40%

LPA
Two
405.000
+152.840
+60.61%

ADA

Naked shorts will just ftd

Thanks Theroc, there are huge strategic decisions to made. Fortunately we have a CEO who understands this. Just to add some color let me quote Jason Huang during the presentation of the NVIDIA quarterly results a few days ago:
“ The next industrial revolution has begun — companies and countri

So the only thing right now that makes us different from Russia, China, Iran, North Korea, or any other enemy is that our leader is obsessed with "ladies" with penises. We have no moral ground to yak at any other country about democracy, election integrity, or rule of law.

Metro Marxists march in lock step. Now the Dem States will be removing Trump from their ballots. "A republic if you can keep it" seems like a prophetic quote at this time.

Share Issuances
3,342,998 of pre-exchange common shares of XTI Aircraft Company were issued to Xeriant, Inc. immediately prior to the XTI Merger closing time or 298,395 post merger exchange common shares. This share issuance to Xeriant Inc. fully settled the obligation relating to a joint ve

Open letter the Walker Crime syndicate.
1. Nobody believes a word you say.
2. Beat it...nobody cares.
ASRE let's moon it.

Tiimayyyy wheel yourself on out of here boy.